# Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy

> **NCT01452113** · PHASE2 · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 21 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Vildagliptin

## Key facts

- **NCT ID:** NCT01452113
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2013-01
- **Final completion:** 2013-03
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-03-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01452113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01452113, "Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01452113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*